All the top Biotech & Pharma news in one daily newsletter.

What to understand how these updates are formatted? Check-out the FAQ.

Have any feedback? I’d love to hear from you! 📣

(You can also reach out to me on LinkedIn)

Last thing - if you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️

THE GOOD
Approvals & Labels

Genentech (Roche) lands FDA approval for Vabysmo prefilled syringe formulation
Bispecific antibody, wet-age macular degeneration, diabetic macular edema, retinal vein occlusion - Read more

THE GOOD
Business Development

iTeos Therapeutics hits clinical milestone, $35M payout from GSK
Monoclonal antibody, lung cancer - Read more

THE GOOD
Clinical Trials

IDEAYA Biosciences’ boo-YA with positive Ph2 results
Small molecule, bladder cancer, lung cancer - Read more

Oxolife births positive exploratory Ph2 data
Small molecule, in vitro fertilization (IVF) - Read more

Adicet Bio handed FDA fast track designation
Cell therapy, gamma delta CAR-T, renal cell carcinoma, cancer - Read more

THE GOOD
Company Launches

KOMO BIOSCIENCES launches as University of Hawaii spin-out
Integrase technology, genome editing - Read more [Paywall]

THE GOOD
Fundraises

SmartCella €50M ($54.1M) raise, with AstraZeneca picking up half the tab
Cardiac progenitor cell therapy, mRNA, drug delivery, medical device - Read more

Vanqua Bio $45M Series B extension
Small molecule, Parkinson’s, Dementia, Alzheimer’s - Read more [Paywall]

Venga Ventures aims to rais­e €40M ($43M)
Biotech investing - Read more [Paywall]

Apriori Bio $1.1M raise
Vaccine development, viral threats, AI - Read more

THE GOOD
Lawsuits

Merck & Co. leaves behind 1k Zostavax lawsuits after plaintiff voluntary dismissal
Vaccine, herpes, chicken pox, shingles - Read more

THE GOOD
Mergers & Acquisitions

Eli Lilly buys Morphic for $3.2B
Small molecule, inflammatory bowel disease (IBD) - Read more

Thermo Fisher gets UK antitrust watchdog OK for $3.1B OLink acquisition
Proteomics, high-throughput protein analysis - Read more

Ligand Pharmaceuticals buys APEIRON Biologics for $100M
Monoclonal antibody, neuroblastoma, cancer - Read more

Alcon buys Belkin Vision for $81M
Selective laser trabeculoplasty, glaucoma, ocular hypertension - Read more

Anacura acquires OHMX.bio (amount undisclosed)
Omics technology, drug discovery, diagnostics - Read more

Grifols fields $6B go-private offer from founding family and an investment firm
Plasma-based medicines, primary immunodeficiencies - Read more

THE GOOD
Product Launches

Genentech (Roche) relaunches wet AMD ocular implant after updates to recalled 2021 design
Monoclonal antibody, neovascular (wet) age-related macular degeneration (nAMD) - Read more

THE GOOD
Regulatory

FDA provides guidance on how industry can clapback at misinformation
Misinformation, disinformation - Read more

THE GOOD
Research

Who has the better weight-loss injectable, Eli Lilly or Novo Nordisk? Study points to the former
GLP-1, obesity, weight-loss - Read more

Novartis’ small molecule shows sickle cell disease potential in animal studies
Small molecule, sickle cell disease - Read more

ENJOYING THESE NEWSLETTERS?
Consider an optional paid subscription.

It’s a lot of work to put together a daily newsletter, and it’s currently just me writing these things (+ one part-time contractor - no fancy editing team!).

If you’re getting value out of these daily compilations, please consider a paid subscription (only $5/month) to support my continued work on this project.

THE BAD
Clinical Trials

HilleVax norovirus vaccine fails Ph2, stock sinks 80%
Virus-like particle-based vaccine, norovirus-related acute gastroenteritis (AGE) - Read more

THE BAD
Fundraises

Inventiva is in serious need of cash, current reserves would last mere weeks
Small molecule, metabolic dysfunction-associated steatohepatitis (MASH), non-alcoholic steatohepatitis (NASH) - Read more

THE BAD
Lawsuits

Gilead’s HIV drug patent battle ain’t over, as Biden administration appeals federal court jury decision
Small molecule, HIV/AIDS, antiretroviral - Read more [Paywall]

Novartis accused of neglecting development of an acquired asset from (and thus avoiding milestone payouts to) Admune Therapeutics - Read more [Paywall]

THE BAD
Strategic Plans

Aerovate Therapeutics begins exploring “strategic alternatives” after Ph2b trial failure last week
Small molecule, pulmonary arterial hypertension - Read more 

THE UGLY
Research

The cause of most non-relapse deaths after CAR-T? Infections; study
CAR-T cell therapy - Read more 

You’re all caught up on the latest Pharma & Biotech News!

TLDR Biotech wants to hear from you! 📣 

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

Want to sponsor this newsletter and reach an audience of 500+ biotech and pharma professionals? Reach us here. 👍

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here.